{"log_id": 5424701055194243653, "direction": 0, "words_result_num": 39, "words_result": [{"probability": {"variance": 0.006166, "average": 0.975612, "min": 0.521766}, "location": {"width": 803, "top": 244, "height": 45, "left": 242}, "words": "有不良影响的剂量出现在按mgkg剂量给药(人体重75kg)超过临床剂量(7.515mg)5至"}, {"probability": {"variance": 0.000631, "average": 0.991024, "min": 0.872783}, "location": {"width": 799, "top": 273, "height": 43, "left": 245}, "words": "10倍时。已报导与所有的前列腺素合成抑制剂一样,胚胎毒性出现在妊娠末期。体内和体外"}, {"probability": {"variance": 0.000199, "average": 0.9953, "min": 0.919013}, "location": {"width": 635, "top": 303, "height": 40, "left": 243}, "words": "试验均未显示任何致突变性。大鼠和小鼠在高于临床剂量时未发现致癌性"}, {"probability": {"variance": 3e-06, "average": 0.998278, "min": 0.99424}, "location": {"width": 131, "top": 362, "height": 29, "left": 249}, "words": "【药代动力学】"}, {"probability": {"variance": 1e-06, "average": 0.998576, "min": 0.997466}, "location": {"width": 48, "top": 395, "height": 23, "left": 240}, "words": "吸收"}, {"probability": {"variance": 0.003186, "average": 0.981232, "min": 0.673089}, "location": {"width": 805, "top": 406, "height": 41, "left": 243}, "words": "美洛昔康经胃肠道能很好地吸收,口服(胶囊)后绝对生物利用度达89%。片剂、口服混悬"}, {"probability": {"variance": 3e-06, "average": 0.99855, "min": 0.993957}, "location": {"width": 220, "top": 445, "height": 30, "left": 244}, "words": "液与胶囊具有生物等效性"}, {"probability": {"variance": 0.000727, "average": 0.99011, "min": 0.850023}, "location": {"width": 804, "top": 484, "height": 41, "left": 244}, "words": "服用单剂量美洛昔康,最高血浆浓度口服混悬液出现在2小时内,口服固体制剂出现在5-6小"}, {"probability": {"variance": 0.000174, "average": 0.994586, "min": 0.940606}, "location": {"width": 805, "top": 511, "height": 41, "left": 245}, "words": "时(胶囊和片剂)。服用多剂量,三至五天可进入稳定状态。每日一次剂量使药物血浆浓度"}, {"probability": {"variance": 0.006706, "average": 0.964017, "min": 0.586351}, "location": {"width": 807, "top": 538, "height": 41, "left": 245}, "words": "在一相当小的峰一谷间波动,7.5mg剂量的波动范围是0.4-1.0ugml,15mg剂量的血浆浓度范"}, {"probability": {"variance": 0.005701, "average": 0.970814, "min": 0.630292}, "location": {"width": 799, "top": 564, "height": 42, "left": 244}, "words": "围是0.8-2.0μg/ml(分别为稳态时的Cmn和Cmax)。对于稳定状态时美洛昔的最高血浆浓度"}, {"probability": {"variance": 0.000286, "average": 0.993975, "min": 0.900262}, "location": {"width": 802, "top": 592, "height": 40, "left": 247}, "words": "片剂、胶囊和口服悬液分别需要5-6小时达到。连续治疗一年以上的患者体内药物浓度和初"}, {"probability": {"variance": 0.00071, "average": 0.992541, "min": 0.858442}, "location": {"width": 530, "top": 622, "height": 38, "left": 252}, "words": "次进入稳定状态的患者相似。进食时服用药物对吸收没有影响"}, {"probability": {"variance": 0, "average": 0.999451, "min": 0.998922}, "location": {"width": 45, "top": 683, "height": 24, "left": 246}, "words": "分布"}, {"probability": {"variance": 0.004339, "average": 0.975515, "min": 0.697959}, "location": {"width": 803, "top": 693, "height": 43, "left": 250}, "words": "美洛昔几乎完全与血浆蛋白结合,主要为白蛋白(99%)。美洛昔康能穿透进入滑液,浓度"}, {"probability": {"variance": 4e-06, "average": 0.998511, "min": 0.993308}, "location": {"width": 179, "top": 732, "height": 28, "left": 247}, "words": "接近在血浆中的一半"}, {"probability": {"variance": 0.001519, "average": 0.982149, "min": 0.852975}, "location": {"width": 488, "top": 751, "height": 38, "left": 247}, "words": "分布体积小,平均为11升。个体间差异可达到30-40%"}, {"probability": {"variance": 0.000363, "average": 0.987667, "min": 0.954698}, "location": {"width": 82, "top": 809, "height": 24, "left": 248}, "words": "生物转化"}, {"probability": {"variance": 0.000842, "average": 0.989555, "min": 0.863141}, "location": {"width": 804, "top": 820, "height": 41, "left": 248}, "words": "美洛昔康在肝脏彻底生物转化。在尿中得到四种代谢产物,均没有药效学活性。主要代谢产"}, {"probability": {"variance": 0.003215, "average": 0.978804, "min": 0.744126}, "location": {"width": 807, "top": 846, "height": 41, "left": 248}, "words": "物为52-羧基美洛昔康(剂量的60%)是由中间产物5羟甲基美洛昔康氧化形成的,后者也有"}, {"probability": {"variance": 0.000568, "average": 0.989002, "min": 0.851119}, "location": {"width": 806, "top": 872, "height": 40, "left": 248}, "words": "较少程度的排出(剂量的9%)。体外试验显示CYP2C9在代谢途径中起重要作用,而CYP3A4"}, {"probability": {"variance": 0.000257, "average": 0.995948, "min": 0.898279}, "location": {"width": 804, "top": 897, "height": 42, "left": 250}, "words": "同工酶的贡献较少。患者的过氧化物酶活性可能与另外两个代谢物的形成有关,它们分别占"}, {"probability": {"variance": 5.8e-05, "average": 0.995994, "min": 0.972443}, "location": {"width": 190, "top": 938, "height": 23, "left": 249}, "words": "服用剂量的16%和49"}, {"probability": {"variance": 0, "average": 0.999089, "min": 0.998911}, "location": {"width": 44, "top": 986, "height": 23, "left": 249}, "words": "消除"}, {"probability": {"variance": 0.008957, "average": 0.978572, "min": 0.405111}, "location": {"width": 810, "top": 999, "height": 40, "left": 249}, "words": "美洛昔几乎完全以代谢物的形式排出,经尿或粪便的排泄量相等。从粪便中排泄的原形药"}, {"probability": {"variance": 0.000148, "average": 0.994425, "min": 0.933813}, "location": {"width": 568, "top": 1027, "height": 38, "left": 251}, "words": "物少于每日剂量的5%,只有痕量的未改变的原化合物从尿中排出"}, {"probability": {"variance": 0.010559, "average": 0.97008, "min": 0.435507}, "location": {"width": 587, "top": 1054, "height": 37, "left": 253}, "words": "美洛昔康从体内排除的平均半衰期是20小时。平均血浆清除率为8"}, {"probability": {"variance": 0.001193, "average": 0.98585, "min": 0.801956}, "location": {"width": 678, "top": 1100, "height": 71, "left": 252}, "words": "口服或肌注给予治疗量7.5mg和15mg美洛昔康,其药代动力学呈线性。"}, {"probability": {"variance": 0.026219, "average": 0.925515, "min": 0.563464}, "location": {"width": 108, "top": 1112, "height": 26, "left": 253}, "words": "线性/非线性"}, {"probability": {"variance": 2.9e-05, "average": 0.995831, "min": 0.986791}, "location": {"width": 83, "top": 1189, "height": 26, "left": 253}, "words": "特殊人群"}, {"probability": {"variance": 0.029872, "average": 0.924697, "min": 0.501674}, "location": {"width": 129, "top": 1217, "height": 27, "left": 253}, "words": "肝/肾功能不全"}, {"probability": {"variance": 0.000182, "average": 0.994224, "min": 0.929876}, "location": {"width": 787, "top": 1231, "height": 41, "left": 253}, "words": "肝功能不全或轻、中度肾功能不全对美洛昔康药代动力学均无较大影响。对晚期肾衰患者"}, {"probability": {"variance": 0.005039, "average": 0.978806, "min": 0.562898}, "location": {"width": 810, "top": 1258, "height": 45, "left": 252}, "words": "由于分布容积增加会导致游离美洛昔康浓度升高,因此不得超过每75mg剂量(参见【用"}, {"probability": {"variance": 0.021051, "average": 0.917534, "min": 0.627604}, "location": {"width": 95, "top": 1299, "height": 25, "left": 254}, "words": "法用量】)"}, {"probability": {"variance": 9e-06, "average": 0.997727, "min": 0.99256}, "location": {"width": 84, "top": 1350, "height": 27, "left": 256}, "words": "老年患者"}, {"probability": {"variance": 6.2e-05, "average": 0.997655, "min": 0.958759}, "location": {"width": 519, "top": 1366, "height": 39, "left": 257}, "words": "与青年人相比,老年人的稳定状态平均血浆清除率略有降低"}, {"probability": {"variance": 1e-06, "average": 0.998627, "min": 0.997077}, "location": {"width": 68, "top": 1427, "height": 23, "left": 265}, "words": "【贮藏】"}, {"probability": {"variance": 0.00518, "average": 0.977675, "min": 0.691294}, "location": {"width": 305, "top": 1448, "height": 29, "left": 257}, "words": "遮光、密封存放于30°℃以下环境!"}, {"probability": {"variance": 0.007791, "average": 0.961993, "min": 0.714379}, "location": {"width": 260, "top": 1476, "height": 31, "left": 257}, "words": "请存放于儿童伸手不能触及处"}], "language": 3}